Program Book - Confex

ACR/ARHP Poster Session B
Distler 9 and Yannick Allanore 1 , 1 Paris Descartes University,
Rheumatology A department, Cochin Hospital, Paris,
France, 2 Department of Internal Medicine, Rheumatology
Section, Transition Clinic, University of Florence, Firenze,
Italy, 3 Center of Experimental Rheumatology, University
Hospital Zurich, Zurich, Switzerland, 4 Charité University
Hospital, German Rheumatology Research Center, a Leibniz
Institute, Berlin, Germany, 5 Ospedale Mauriziano, Torino,
Italy, 6 Rheumatology Department, Saint Lucas Hospital,
Pontifical Catholic University of Rio Grande do Sul, Porto
Alegre, Brazil, Porto Alegre, Brazil, 7 Chair of Rheumatology
II, Department of Medical Sciences, University of Cagliari,
Italy, Cagliari, Italy, 8 Brescia, Italy, 9 University Hospital Zurich,
Zurich, Switzerland
1463. Features of Acute Denervation in Scleroderma Myopathy.
Julie J. Paik, Fredrick M. Wigley, Laura K. Hummers and
Andrew L. Mammen, Johns Hopkins University, Baltimore,
MD
1464. Medium and Large Vessel Involvements Contribute to
Digital Ulcers in Systemic Sclerosis. Christophe Meune 1 ,
Marine Meunier 2 , Jérôme Avouac 2 , Andre Kahan 2 and
Yannick Allanore 2 , 1 Paris Descartes University, Cardiology
department, Cochin Hospital, Paris, France, 2 Paris Descartes
University, Rheumatology A department, Cochin Hospital,
Paris, France
1465. Juvenile Systemic Sclerosis Outcomes After Treatment
of Pulmonary Fibrosis with Cyclophosphamide or
Methotrexate. Gretchen R. Henstorf 1 and Anne M.
Stevens 2 , 1 Seattle Children’s Research Institute, Seattle, WA,
2
University of Washington, Seattle, WA
1466. The N-Terminal Fragment of Brain Natriuretic Peptide As
An Outcome Predictor in Scleroderma Renal Crisis. Cecilia
B. Chighizola 1 , Henry Penn 2 , Pier Luigi Meroni 1 , Christopher
D. Denton 3 and Voon Ong 4 , 1 University of Milan, Milan,
Italy, 2 Northwick Park Hospital, Harrow, United Kingdom,
3
Royal Free Hospital, Medical School, London, England, 4 UCL
Medical School, London, England
1467. Systemic Sclerosis-Related Digital Ulcers: Influence of
Location, Calcinosis and Perfusion on Time to Healing.
Andrea Murray 1 , Tonia Moore 1 , Elizabeth Wragg 2 , Holly
Ennis 1 , Andy Vail 3 , Adrienne Taylor 2 , Graham Dinsdale 1 ,
Lindsay Muir 4 , Charles Hutchinson 1 , Christopher E.M
Griffiths 5 and Ariane Herrick 1 , 1 School of Translational
Medicine, University of Manchester, Manchester Academic
Health Science Centre, Manchester, United Kingdom,
2
Rheumatology Directorate, Salford Royal NHS Foundation
Trust, Salford, United Kingdom, 3 School of Community Based
Medicine, University of Manchester, Manchester Academic
Health Science Centre, Salford, United Kingdom, 4 Hand
Surgery, Salford Royal NHS Foundation Trust, Salford, United
Kingdom, 5 University of Manchester, Manchester Academic
Health Science Centre, Manchester, United Kingdom
1468. Spectrum of Muscle Disease in Scleroderma. Huma
Sohail 1 , Ann J. Impens 2 , Elena Schiopu 2 and Kristine Phillips 3 ,
1
University Of Michigan, Ann Arbor, MI, 2 University of
Michigan, Ann Arbor, MI, 3 University of Michigan Medical
School, Ann Arbor, MI
1469. Circulating Endothelial cells and Capillaroscopic Skin
Ulcer risk index (CSURI) As Biomarkers of scleroderma
microvascular Injury. Silvia L. Bosello, Mario Bocci,
Giacomo De Luca, Annunziata Capacci, Barbara Tolusso and
Gianfranco Ferraccioli, Division of Rheumatology, Catholic
University of the Sacred Heart, Rome, Italy
1470. Living with Connective Tissue Related Interstitial Lung
Disease: Patient Experiences of the Disease Process Over
Time. Shikha Mittoo 1 , Lesley Ann Saketkoo 2 , Jeffery J.
Swigris 3 , Daphne LeSage 4 , Aryeh Fischer 3 and Sid Frankel 5 ,
1
University of Toronto, Toronto, ON, 2 LSU Health Science
Center, New Orleans, LA, 3 National Jewish Health, Denver,
CO, 4 Center for CCH at State of Louisiana, New Orleans, LA,
5
University of Manitoba, Winnipeg
1471. Functional Class Change in Patients with Connective Tissue
Disease-Associated Pulmonary Arterial Hypertension:
Associations with Survival and Exercise Capacity. Lorinda
Chung 1 , Lori S. Parsons 2 , Paul M. Hassoun 3 , Michael D.
McGoon 4 , David B. Badesch 5 , Dave P. Miller 2 , Mark R. Nicolls 6
and Roham T. Zamanian 6 , 1 Stanford Univ Medical Center,
Palo Alto, CA, 2 ICON Late Phase & Outcomes Research, San
Francisco, CA, 3 Johns Hopkins University, Baltimore, MD,
4
Mayo Clinic, Rochester, MN, 5 University of Colorado Denver,
Aurora, CO, 6 Stanford University, Stanford, CA
1472. Serum Interleukin-9 Levels Are Increased In Patients with
Systemic Sclerosis: Association with Lower Frequency and
Severity of Pulmonary Fibrosis. Koichi Yanaba and Shinichi
Sato, The University of Tokyo, Tokyo, Japan
1473. High-Dose I.v. N-Acetylcysteine Increases Peripheral Tissue
Perfusion and Improves Clinical Symptoms of Systemic
Sclerosis Patients. A Pilot Study. Alberto Sulli, Barbara
Ruaro, Giuseppe Zampogna, Carmela Ferrone, Francesca
Ravera, Bruno Seriolo and Maurizio Cutolo, Research
Laboratory and Academic Unit of Clinical Rheumatology,
Department of Internal Medicine, University of Genova,
Genoa, Italy
1474. Progression of Microvascular Damage Through Different
Nailfold Capillaroscopic Patterns in Systemic Sclerosis
Patients. Alberto Sulli 1 , Francesca Ravera 1 , Barbara Ruaro 1 ,
Vanessa Smith 2 , Carmen Pizzorni 1 , Giuseppe Zampogna 1 ,
Elisa Alessandri 1 and Maurizio Cutolo 1 , 1 Research Laboratory
and Academic Unit of Clinical Rheumatology, Department
of Internal Medicine, University of Genova, Genoa, Italy,
2
Department of Rheumatology, Ghent University Hospital,
Ghent, Belgium
1475. Serum Brain Natriuretic Peptide is a Reliable Marker for
Survival of Pulmonary Arterial Hypertension Associated
with Connective Tissue Diseases, Including Systemic
2011 Program Book 241